Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2019

01-07-2019 | Astrocytoma | Original Article

Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas

Authors: Arnoldo Piccardo, Domenico Tortora, Samantha Mascelli, Mariasavina Severino, Gianluca Piatelli, Alessandro Consales, Marco Pescetto, Veronica Biassoni, Elisabetta Schiavello, Michela Massollo, Antonio Verrico, Claudia Milanaccio, Maria Luisa Garrè, Andrea Rossi, Giovanni Morana

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2019

Login to get access

Abstract

Purpose

The aim of this study was to investigate MRI-derived diffusion weighted imaging (DWI), 1H-MR spectroscopy (1H-MRS) and arterial spin labeling (ASL) perfusion imaging in comparison with 18F-dihydroxyphenylalanine (DOPA) PET with respect to diagnostic evaluation of pediatric diffuse midline gliomas (DMG) H3K27M-mutant and wild-type.

Methods

We retrospectively analyzed 22 pediatric patients with DMG histologically proved and molecularly classified as H3K27M-mutant (12 subjects) and wild-type (10 subjects) who underwent DWI, 1H-MRS, and ASL performed within 2 weeks of 18F-DOPA PET. DWI-derived relative minimum apparent diffusion coefficient (rADC min), 1H-MRS data [choline/N-acetylaspartate (Cho/NAA), choline/creatine (Cho/Cr), and presence of lactate] and relative ASL-derived cerebral blood flow max (rCBF max) were compared with 18F-DOPA uptake Tumor/Normal tissue (T/N) and Tumor/Striatum (T/S) ratios, and correlated with histological and molecular features of DMG. Statistics included Pearson’s chi-square and Mann-Whitney U tests, Spearman’s rank correlation and receiver operating characteristic (ROC) analysis.

Results

The highest degrees of correlation among different techniques were found between T/S, rADC min and Cho/NAA ratio (p < 0.01), and between rCBF max and rADC min (p < 0.01). Significant differences between histologically classified low- and high-grade DMG, independently of H3K27M-mutation, were found among all imaging techniques (p ≤ 0.02). Significant differences in terms of rCBF max, rADC min, Cho/NAA and 18F-DOPA uptake were also found between molecularly classified mutant and wild-type DMG (p ≤ 0.02), even though wild-type DMG included low-grade astrocytomas, not present among mutant DMG. When comparing only histologically defined high-grade mutant and wild-type DMG, only the 18F-DOPA PET data T/S demonstrated statistically significant differences independently of histology (p < 0.003). ROC analysis demonstrated that T/S ratio was the best parameter for differentiating mutant from wild-type DMG (AUC 0.94, p < 0.001).

Conclusions

Advanced MRI and 18F-DOPA PET characteristics of DMG depend on histological features; however, 18F-DOPA PET-T/S was the only parameter able to discriminate H3K27M-mutant from wild-type DMG independently of histology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20.CrossRefPubMed Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20.CrossRefPubMed
2.
go back to reference Louis DN, Giannini C, Capper D, Paulus W, Figarella-Branger D, Lopes MB, et al. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol. 2018;135:639–42.CrossRefPubMed Louis DN, Giannini C, Capper D, Paulus W, Figarella-Branger D, Lopes MB, et al. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol. 2018;135:639–42.CrossRefPubMed
3.
go back to reference Aboian MS, Solomon DA, Felton E, Mabray MC, Villanueva-Meyer JE, Mueller S, et al. Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. AJNR Am J Neuroradiol. 2017;38:795–800.CrossRefPubMedPubMedCentral Aboian MS, Solomon DA, Felton E, Mabray MC, Villanueva-Meyer JE, Mueller S, et al. Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation. AJNR Am J Neuroradiol. 2017;38:795–800.CrossRefPubMedPubMedCentral
5.
go back to reference Rossi A, Gandolfo C, Morana G, Severino M, Garrè ML, Cama A. New MR sequences (diffusion, perfusion, spectroscopy) in brain tumours. Pediatr Radiol. 2010;40:999–1009.CrossRefPubMed Rossi A, Gandolfo C, Morana G, Severino M, Garrè ML, Cama A. New MR sequences (diffusion, perfusion, spectroscopy) in brain tumours. Pediatr Radiol. 2010;40:999–1009.CrossRefPubMed
6.
go back to reference Morana G, Piccardo A, Garrè ML, Nozza P, Consales A, Rossi A. Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treated with bevacizumab. J Clin Oncol. 2013;31:e1–5.CrossRefPubMed Morana G, Piccardo A, Garrè ML, Nozza P, Consales A, Rossi A. Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treated with bevacizumab. J Clin Oncol. 2013;31:e1–5.CrossRefPubMed
7.
go back to reference Morana G, Piccardo A, Tortora D, Puntoni M, Severino M, Nozza P, et al. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET. Eur J Nucl Med Mol Imaging. 2017;44:2084–93.CrossRefPubMed Morana G, Piccardo A, Tortora D, Puntoni M, Severino M, Nozza P, et al. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET. Eur J Nucl Med Mol Imaging. 2017;44:2084–93.CrossRefPubMed
8.
go back to reference Morana G, Piccardo A, Puntoni M, Nozza P, Cama A, Raso A, et al. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study. Neuro-Oncology. 2015;17:1637–47.CrossRefPubMedPubMedCentral Morana G, Piccardo A, Puntoni M, Nozza P, Cama A, Raso A, et al. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study. Neuro-Oncology. 2015;17:1637–47.CrossRefPubMedPubMedCentral
9.
go back to reference Morana G, Piccardo A, Garrè ML, Cabria M, Rossi A. 18F-DOPA uptake of developmental venous anomalies in children with brain tumors. Clin Nucl Med. 2016;41:e351–2.CrossRefPubMed Morana G, Piccardo A, Garrè ML, Cabria M, Rossi A. 18F-DOPA uptake of developmental venous anomalies in children with brain tumors. Clin Nucl Med. 2016;41:e351–2.CrossRefPubMed
10.
go back to reference Morana G, Piccardo A, Milanaccio C, Puntoni M, Nozza P, Cama A, et al. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study. J Nucl Med. 2014;55:718–23.CrossRefPubMed Morana G, Piccardo A, Milanaccio C, Puntoni M, Nozza P, Cama A, et al. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study. J Nucl Med. 2014;55:718–23.CrossRefPubMed
11.
go back to reference Berntsson SG, Falk A, Savitcheva I, Godau A, Zetterling M, Hesselager G, et al. Perfusion and diffusion MRI combined with 11C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neuro-Oncol. 2013;11:241–9.CrossRef Berntsson SG, Falk A, Savitcheva I, Godau A, Zetterling M, Hesselager G, et al. Perfusion and diffusion MRI combined with 11C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas. J Neuro-Oncol. 2013;11:241–9.CrossRef
13.
go back to reference Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, et al. Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol. 2014;127:881–95.CrossRefPubMed Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, et al. Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol. 2014;127:881–95.CrossRefPubMed
14.
go back to reference Funato K, Major T, Lewis PW, Allis CD, Tabar V. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science. 2014;346:1529–33.CrossRefPubMedPubMedCentral Funato K, Major T, Lewis PW, Allis CD, Tabar V. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science. 2014;346:1529–33.CrossRefPubMedPubMedCentral
15.
go back to reference Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol. 2015;130:815–27.CrossRefPubMedPubMedCentral Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol. 2015;130:815–27.CrossRefPubMedPubMedCentral
16.
go back to reference Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T, et al. Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun. 2017;5:28.CrossRefPubMedPubMedCentral Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, Tomita T, et al. Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun. 2017;5:28.CrossRefPubMedPubMedCentral
17.
go back to reference Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN, et al. Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clin Cancer Res. 2018;24:5850–9.CrossRefPubMedPubMedCentral Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, Magge SN, et al. Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clin Cancer Res. 2018;24:5850–9.CrossRefPubMedPubMedCentral
18.
go back to reference Yeom KW, Mitchell LA, Lober RM, Barnes PD, Vogel H, Fisher PG, et al. Arterial spin-labeled perfusion of pediatric brain tumors. AJNR Am J Neuroradiol. 2014;35:395–401.CrossRefPubMedPubMedCentral Yeom KW, Mitchell LA, Lober RM, Barnes PD, Vogel H, Fisher PG, et al. Arterial spin-labeled perfusion of pediatric brain tumors. AJNR Am J Neuroradiol. 2014;35:395–401.CrossRefPubMedPubMedCentral
19.
go back to reference Dangouloff-Ros V, Deroulers C, Foissac F, Badoual M, Shotar E, Grévent D, et al. Arterial spin labeling to predict brain tumor grading in children: correlations between histopathologic vascular density and perfusion MR imaging. Radiology. 2016;281:553–66.CrossRefPubMed Dangouloff-Ros V, Deroulers C, Foissac F, Badoual M, Shotar E, Grévent D, et al. Arterial spin labeling to predict brain tumor grading in children: correlations between histopathologic vascular density and perfusion MR imaging. Radiology. 2016;281:553–66.CrossRefPubMed
20.
go back to reference Heiss WD, Raab P, Lanfermann H. Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med. 2011;52:1585–600.CrossRefPubMed Heiss WD, Raab P, Lanfermann H. Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med. 2011;52:1585–600.CrossRefPubMed
21.
go back to reference Fink JR, Muzi M, Peck M, Krohn KA. Multimodality brain tumor imaging: MR imaging, PET, and PET/MR imaging. J Nucl Med. 2015;56:1554–61.CrossRefPubMed Fink JR, Muzi M, Peck M, Krohn KA. Multimodality brain tumor imaging: MR imaging, PET, and PET/MR imaging. J Nucl Med. 2015;56:1554–61.CrossRefPubMed
22.
go back to reference Morana G, Puntoni M, Garrè ML, Massollo M, Lopci E, Naseri M, et al. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma. Eur J Nucl Med Mol Imaging. 2016;43:1664–72.CrossRefPubMed Morana G, Puntoni M, Garrè ML, Massollo M, Lopci E, Naseri M, et al. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma. Eur J Nucl Med Mol Imaging. 2016;43:1664–72.CrossRefPubMed
23.
go back to reference Lequin M, Hendrikse J. Advanced MR imaging in pediatric brain tumors, clinical applications. Neuroimaging Clin N Am. 2017;27:167–90.CrossRefPubMed Lequin M, Hendrikse J. Advanced MR imaging in pediatric brain tumors, clinical applications. Neuroimaging Clin N Am. 2017;27:167–90.CrossRefPubMed
24.
go back to reference Keil VC, Hartkamp NS, Connolly DJA, Morana G, Dremmen MHG, Mutsaerts HJMM, et al. Added value of arterial spin labeling magnetic resonance imaging in pediatric neuroradiology: pitfalls and applications. Pediatr Radiol. 2019;49:245–53.CrossRefPubMed Keil VC, Hartkamp NS, Connolly DJA, Morana G, Dremmen MHG, Mutsaerts HJMM, et al. Added value of arterial spin labeling magnetic resonance imaging in pediatric neuroradiology: pitfalls and applications. Pediatr Radiol. 2019;49:245–53.CrossRefPubMed
25.
go back to reference Morana G, Tortora D, Staglianò S, Nozza P, Mascelli S, Severino M, et al. Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion. Neuroradiology. 2018;60:437–46.CrossRefPubMed Morana G, Tortora D, Staglianò S, Nozza P, Mascelli S, Severino M, et al. Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion. Neuroradiology. 2018;60:437–46.CrossRefPubMed
26.
go back to reference Novak J, Withey SB, Lateef S, MacPherson L, Pinkey B, Peet AC. A comparison of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast MRI with and without contrast agent leakage correction in paediatric brain tumours. Br J Radiol. 2019;92:20170872.CrossRefPubMed Novak J, Withey SB, Lateef S, MacPherson L, Pinkey B, Peet AC. A comparison of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast MRI with and without contrast agent leakage correction in paediatric brain tumours. Br J Radiol. 2019;92:20170872.CrossRefPubMed
27.
go back to reference Hipp SJ, Steffen-Smith EA, Patronas N, Herscovitch P, Solomon JM, Bent RS, et al. Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using 18F-FDG-PET and MRSI. J Neuro-Oncol. 2012;109:521–7.CrossRef Hipp SJ, Steffen-Smith EA, Patronas N, Herscovitch P, Solomon JM, Bent RS, et al. Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using 18F-FDG-PET and MRSI. J Neuro-Oncol. 2012;109:521–7.CrossRef
28.
go back to reference Hourani R, Horska´ A, Albayram S, Brant LJ, Melhem E, Cohen KJ, et al. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging. 2006;23:99–107.CrossRefPubMed Hourani R, Horska´ A, Albayram S, Brant LJ, Melhem E, Cohen KJ, et al. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children. J Magn Reson Imaging. 2006;23:99–107.CrossRefPubMed
29.
go back to reference Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019;46:540–57.CrossRefPubMed Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2019;46:540–57.CrossRefPubMed
30.
go back to reference Barker PB, Bizzi A, De Stefano N, Gullapalli R, Lin DM. MR spectroscopy in brain tumors. In: Barker PB, Bizzi A, De Stefano N, Gullapalli R, Lin DM, editors. Clinical MR spectroscopy: techniques and applications. New York: Cambridge University Press; 2010. pp 61–90. Barker PB, Bizzi A, De Stefano N, Gullapalli R, Lin DM. MR spectroscopy in brain tumors. In: Barker PB, Bizzi A, De Stefano N, Gullapalli R, Lin DM, editors. Clinical MR spectroscopy: techniques and applications. New York: Cambridge University Press; 2010. pp 61–90.
31.
go back to reference Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez-Garcia L, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med. 2015;73:102–16.CrossRefPubMed Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez-Garcia L, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med. 2015;73:102–16.CrossRefPubMed
Metadata
Title
Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas
Authors
Arnoldo Piccardo
Domenico Tortora
Samantha Mascelli
Mariasavina Severino
Gianluca Piatelli
Alessandro Consales
Marco Pescetto
Veronica Biassoni
Elisabetta Schiavello
Michela Massollo
Antonio Verrico
Claudia Milanaccio
Maria Luisa Garrè
Andrea Rossi
Giovanni Morana
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2019
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04333-4

Other articles of this Issue 8/2019

European Journal of Nuclear Medicine and Molecular Imaging 8/2019 Go to the issue